Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics. Lorente-Sorolla C, Bernaola J, Sanchez-Mellado D, Gil-Martinez M, et al. Allergy 2023 Aug 29. doi: 10.1111/all.15872.

Read + Share

Amedeo Smart

Independent Medical Education

Lorente-Sorolla C, Bernaola J, Sanchez-Mellado D, Gil-Martinez M, et al. Long-term immune response accompanies clinical outcomes in severe asthmatics treated with anti-IL-5/IL-5R biologics. Allergy 2023 Aug 29. doi: 10.1111/all.15872.
PMID: 37643083